MedPath
HSA Approval

LASIX TABLET 40 mg

SIN00199P

LASIX TABLET 40 mg

LASIX TABLET 40 mg

March 28, 1988

SANOFI-AVENTIS SINGAPORE PTE. LTD.

SANOFI-AVENTIS SINGAPORE PTE. LTD.

Regulatory Information

SANOFI-AVENTIS SINGAPORE PTE. LTD.

SANOFI-AVENTIS SINGAPORE PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

TABLET

**Dosage** In general, the dose used must be the lowest which is sufficient to achieve the desired effect. Unless otherwise prescribed, the following dosage guidelines apply: In adults, treatment is usually started with 1/2–1–2 tablets daily; the maintenance dose is 1/2–1 tablet daily. In infants and children, Lasix should in principle be administered orally. The dosage recommendation is 2 mg furosemide per kg body weight up to a daily maximum of 40 mg. Parenteral administration (if necessary, continuous drip infusion) is indicated only in life-threatening conditions.

ORAL

Medical Information

**Indications** Oedema due to cardiac, hepatic, or renal disorders (in the presence of nephrotic syndrome, treatment of the basic disorder is the prime concern). Oedema due to burns. Mild to moderate hypertension.

**Contraindications** Lasix must not be used in patients with: - renal failure accompanied by lack of urine formation (anuria) in patients not responding to furosemide - hepatic coma and precoma - severely reduced blood levels of potassium (hypokalaemia – see Adverse Reaction – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_), or of sodium (hyponatraemia) - decreased volume of blood in the body (hypovolaemia) – with or without reduced blood pressure (hypotension) – or dehydration - hypersensitivity to furosemide or any of the excipients (see “Composition” – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). Patients allergic to sulphonamides (e.g. sulphonamide antibiotics or sulphonylureas) may show cross-sensitivity to furosemide. - lactation

C03CA01

furosemide

Manufacturer Information

SANOFI-AVENTIS SINGAPORE PTE. LTD.

Opella Healthcare International SAS

Active Ingredients

FUROSEMIDE

40.00 mg

Furosemide

Documents

Package Inserts

Lasix Tab 40mg PI.pdf

Approved: August 25, 2022

Download
© Copyright 2025. All Rights Reserved by MedPath